| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |